Drawing for EMRXCEL

USPTO serial 87253234

EMRXCEL

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
AIKENS, RONALD E
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EMRXCEL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lawrence H. Meier

LAWRENCE H. MEIER DOWNS RACHLIN MARTIN PLLC199 MAIN STREETBURLINGTON, VT 05401UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Administration of prescription discount drug programs; providing discounted pricing on prescription drugs to patients participating in discount card program; providing prescription discount drug program identification codes to pharmacists at the point of prescribing to provide applicable prescription drug pricing for patient prescriptionsACTIVE—
042Software as a service (SAAS) featuring healthcare software for determining whether or not patients have picked up drug prescriptions on a timely basis; SAAS featuring heathcare software for generating and providing reports to healthcare providers and institutions regarding patient compliance with drug prescriptions prescribed by healthcare providers; impact reporting for heathcare systems with respect to patient use of drug prescription; impact reporting for healthcare systems with respect to percentage of patients filling drug prescriptions using a discount drug program, amount of savings by patients participating in a prescription discount drug program, types of prescription drugs provided to patients in a prescription discount drug program ranked by savings, prescriptions filled by individual patients of specific prescribers in a healthcare system, prescriptions filled by individual facilities in a healthcare system, or prescriptions filled by name and location of pharmacyACTIVE—
044Pharmacy benefit analysis services, namely, assessing whether patients are picking up drug prescriptions on a timely basis and notifying healthcare providers and institutions of non-compliant patients based on such assessment, including categorizing non-compliant patients by various metrics for purposes of health monitoring ; pharmacy benefit analysis services, namely, providing reports with respect to patients who are not filling prescriptions on a timely basis, categorized by therapy codes, by facility, by prescriber or practice name, by medication name, or by date range for purposes of health monitoring ; data analytics in the healthcare field, namely, assessing patient compliance with taking prescription drugs as prescribed for purposes of health monitoringACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Dec 23, 2019MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 23, 2019ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 23, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 21, 2019EX3GSOU EXTENSION 3 GRANTED—
May 21, 2019EXT3SOU EXTENSION 3 FILED—
May 21, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 2, 2019ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Dec 4, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 3, 2018EX2GSOU EXTENSION 2 GRANTED—
Dec 3, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 21, 2018EXT2SOU EXTENSION 2 FILED—
Nov 21, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 23, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 21, 2018EX1GSOU EXTENSION 1 GRANTED—
May 21, 2018EXT1SOU EXTENSION 1 FILED—
May 21, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 21, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 26, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 26, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 6, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 14, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 14, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Aug 14, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 14, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 14, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 7, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 7, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 7, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 6, 2017DOCKASSIGNED TO EXAMINER—
Dec 6, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 5, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance